[HTML][HTML] The inhibitory receptor Siglec-8 interacts with FcεRI and globally inhibits intracellular signaling in primary mast cells upon activation

W Korver, A Wong, S Gebremeskel, GL Negri… - Frontiers in …, 2022 - frontiersin.org
Immunomodulation of mast cell (MC) activity is warranted in allergic and inflammatory
diseases where MCs have a central role in pathogenesis. Targeting Siglec-8, an inhibitory …

The Inhibitory Receptor Siglec-8 Interacts With FceRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation

W Korver, A Wong, S Gebremeskel… - Novel Insights into …, 2023 - books.google.com
Immunomodulation of mast cell (MC) activity is warranted in allergic and inflammatory
diseases where MCs have a central role in pathogenesis. Targeting Siglec-8, an inhibitory …

[PDF][PDF] The Inhibitory Receptor Siglec-8 Interacts With FceRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation

W Korver, A Wong, S Gebremeskel, GL Negri… - Front. Immunol. 13 …, 2022 - allakos.com
Immunomodulation of mast cell (MC) activity is warranted in allergic and inflammatory
diseases where MCs have a central role in pathogenesis. Targeting Siglec-8, an inhibitory …

The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation

W Korver, A Wong, S Gebremeskel… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Immunomodulation of mast cell (MC) activity is warranted in allergic and inflammatory
diseases where MCs have a central role in pathogenesis. Targeting Siglec-8, an inhibitory …

The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation.

W Korver, A Wong, S Gebremeskel, GL Negri… - Frontiers in …, 2022 - europepmc.org
Immunomodulation of mast cell (MC) activity is warranted in allergic and inflammatory
diseases where MCs have a central role in pathogenesis. Targeting Siglec-8, an inhibitory …

[HTML][HTML] The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation

W Korver, A Wong, S Gebremeskel, GL Negri… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Immunomodulation of mast cell (MC) activity is warranted in allergic and inflammatory
diseases where MCs have a central role in pathogenesis. Targeting Siglec-8, an inhibitory …

The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation

W Korver, A Wong, S Gebremeskel, GL Negri… - Frontiers in …, 2022 - cir.nii.ac.jp
抄録< jats: p> Immunomodulation of mast cell (MC) activity is warranted in allergic and
inflammatory diseases where MCs have a central role in pathogenesis. Targeting Siglec-8 …

The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation.

W Korver, A Wong, S Gebremeskel, GL Negri… - Frontiers in …, 2022 - europepmc.org
Immunomodulation of mast cell (MC) activity is warranted in allergic and inflammatory
diseases where MCs have a central role in pathogenesis. Targeting Siglec-8, an inhibitory …

[PDF][PDF] The Inhibitory Receptor Siglec-8 Interacts with FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation

W Korver, A Wong, S Gebremeskel, GL Negri… - Presented at the …, 2022 - allakos.com
The Inhibitory Receptor Siglec-8 Interacts with FcεRI and Globally Inhibits Intracellular Signaling
in Primary Mast Cells Upon Page 1 BACKGROUND The Inhibitory Receptor Siglec-8 Interacts …